Anticonvulsant activity of a metabotropic glutamate receptor 8 preferential agonist, (R,S)-4-phosphonophenylglycine

被引:43
作者
Chapman, AG [1 ]
Nanan, K [1 ]
Yip, P [1 ]
Meldrum, BS [1 ]
机构
[1] Univ London Kings Coll, Inst Psychiat, Dept Clin Neurosci, London SE5 8AF, England
关键词
epilepsy; mglu(8) receptor; L-serine-O-phosphate; glutamate receptor metabotropic; (DBA/2 mice); anticonvulsant;
D O I
10.1016/S0014-2999(99)00615-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Agonists at group III glutamate metabotropic receptors, such as L-serine-O-phosphate, have pro- and anti-convulsant activities in rodent models. We have used intracerebroventricular administration to test a novel group III agonist, (R,S)4-phosphonophenylglycine (PPG), that is preferential for mglu(8), against sound-induced seizures in DBA/2 mice. Tonic and clonic seizures are abolished at 15 min (ED50s 0.14 [0.04-0.4] nmol, and 3.4 [2.1-5.6] nmol, respectively). The protection against tonic and clonic seizures by 20 nmol PPG is complete for 4 h, diminished by 6 h, and absent by 10 h. In contrast, L-Serine-O-phosphate gives only partial protection against sound-induced clonic seizures for 15-30 min (ED50 79 [45-139] nmol) in DBA/2 mice. In genetically epilepsy prone rats sound-induced seizures were blocked 5-60 min after the bilateral administration of PPG, 5-10 nmol, into the inferior colliculus. These data suggest that the mglu(8) receptor is a potential target for novel antiepileptic drugs. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:23 / 27
页数:5
相关论文
共 15 条
[1]   Anticonvulsant actions of LY 367385 ((+)-2-methyl-4-carboxyphenylglycine) and AIDA ((RS)-1-aminoindan-1,5-dicarboxylic acid) [J].
Chapman, AG ;
Yip, PK ;
Yap, JS ;
Quinn, LP ;
Tang, E ;
Harris, JR ;
Meldrum, BS .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 368 (01) :17-24
[2]   Pharmacology and functions of metabotropic glutamate receptors [J].
Conn, PJ ;
Pin, JP .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1997, 37 :205-237
[3]  
Flor P. J., 1998, Society for Neuroscience Abstracts, V24, P1089
[4]  
Gasparini F, 1999, J PHARMACOL EXP THER, V289, P1678
[5]   Convulsant and anticonvulsant actions of agonists and antagonists of group III mGluRs [J].
Ghauri, M ;
Chapman, AG ;
Meldrum, BS .
NEUROREPORT, 1996, 7 (09) :1469-1474
[6]  
JOBE PC, 1973, J PHARMACOL EXP THER, V184, P1
[7]  
LITCHFIELD JT, 1949, J PHARMACOL EXP THER, V96, P99
[8]  
NAKAJIMA Y, 1993, J BIOL CHEM, V268, P11868
[9]  
OKAMOTO N, 1994, J BIOL CHEM, V269, P1231
[10]  
PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G